Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin A Storr

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Pharmacological Reports : PR|December 15, 2012
New neostigmine-based behavioral mouse model of abdominal painJakub Fichna, Tamia Lapointe, Kevin Chapman, et al.
Inflammatory Bowel Diseases|May 2, 2009
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitisMartin A Storr, Catherine M Keenan, Hong Zhang, et al.
Chemical Biology & Drug Design|May 12, 2010
The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitroJakub Fichna, Renata Perlikowska, Katarzyna Gach, et al.
Nature Reviews. Gastroenterology & Hepatology|September 3, 2010
Juvenile polyposis of the stomach--a novel cause of hypergastrinemiaKaren D Papay, Vincent G Falck, Steen S Poulsen, et al.
Inflammatory Bowel Diseases|September 29, 2011
Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptorsJakub Fichna, Michael Dicay, Kevin Lewellyn, et al.
Cytokine|December 20, 2011
Cytokines and irritable bowel syndrome: where do we stand?Mohammad Bashashati, Nima Rezaei, Christopher N Andrews, et al.
Regulatory Peptides|January 20, 2010
Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tractJakub Fichna, Katarzyna Gach, Renata Perlikowska, et al.
Journal of Inflammation (London, England)|July 16, 2016
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitmentRegina M Krohn, Sean A Parsons, Jakub Fichna, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2008
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptorsMartin A Storr, Catherine M Keenan, Dominik Emmerdinger, et al.
Nature Communications|March 29, 2013
Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activitySabine Klein, Barbara Seidler, Anna Kettenberger, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pharmacological Reports : PR|December 15, 2012
New neostigmine-based behavioral mouse model of abdominal painJakub Fichna, Tamia Lapointe, Kevin Chapman, et al.
Inflammatory Bowel Diseases|May 2, 2009
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitisMartin A Storr, Catherine M Keenan, Hong Zhang, et al.
Chemical Biology & Drug Design|May 12, 2010
The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitroJakub Fichna, Renata Perlikowska, Katarzyna Gach, et al.
Nature Reviews. Gastroenterology & Hepatology|September 3, 2010
Juvenile polyposis of the stomach--a novel cause of hypergastrinemiaKaren D Papay, Vincent G Falck, Steen S Poulsen, et al.
Inflammatory Bowel Diseases|September 29, 2011
Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptorsJakub Fichna, Michael Dicay, Kevin Lewellyn, et al.
Cytokine|December 20, 2011
Cytokines and irritable bowel syndrome: where do we stand?Mohammad Bashashati, Nima Rezaei, Christopher N Andrews, et al.
Regulatory Peptides|January 20, 2010
Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tractJakub Fichna, Katarzyna Gach, Renata Perlikowska, et al.
Journal of Inflammation (London, England)|July 16, 2016
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitmentRegina M Krohn, Sean A Parsons, Jakub Fichna, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2008
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptorsMartin A Storr, Catherine M Keenan, Dominik Emmerdinger, et al.
Nature Communications|March 29, 2013
Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activitySabine Klein, Barbara Seidler, Anna Kettenberger, et al.
Pageof 3